This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Tracey Burr, Ph.D.
Executive Director, CMC Regulatory Affairs at Ionis Pharmaceuticals
Speaker

Profile

Tracey Burr is Executive Director of CMC Regulatory Affairs at Ionis Pharmaceuticals and is responsible for Ionis’ early and late phase, as well as commercial compounds. She has 20 years of drug development and global CMC regulatory experience and has spent her career working at small to mid-size pharmaceutical and biotechnology companies. Tracey received a Ph. D. in Materials Science and Engineering from MIT, M.Sc. in Chemistry from Caltech, and BA in Chemistry from Wellesley College.

Agenda Sessions

  • Regulatory CMC Strategies and Health Authority Interactions for Oligonucleotide Programs

    08:35